EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pediatric gigantism due to ectopic growth hormone releasing hormone secretion from a metastatic bronchial neuroendocrine tumor

Fernando Vidal-Ostos De Lara iD, David Sanchis-Pascual iD, Lorena Hernández-Rienda iD, María Isabel Del Olmo-García iD

JCEM Case Reports · 16.10.2026 · 4 (12)

DOI: 10.1210/jcemcr/luag304 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 06.11.2026. Verfasst von Fernando Vidal-Ostos De Lara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital Universitario Príncipe de Asturias, Madrid 28806, Spain. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recordati Rare Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric gigantism due to ectopic secretion of growth hormone–releasing hormone (GHRH) is exceptionally rare. Most pediatric reports have involved pancreatic neuroendocrine tumors in the context of multiple endocrine neoplasia 1 (MEN1). We describe a female patient diagnosed at 9 years of age with a typical bronchial neuroendocrine tumor and subsequently found to have diffuse hepatic and skeletal metastases, accelerated linear growth, and acromegalic features. Evaluation demonstrated markedly elevated plasma GHRH, growth hormone, and insulin-like growth factor 1, with diffuse pituitary hyperplasia on magnetic resonance imaging and no discrete pituitary adenoma. Genetic testing for MEN1 was negative. Management required repeated surgery, first-generation somatostatin analogs, dopamine agonist therapy, pegvisomant, pasireotide, and peptide receptor radionuclide therapy with lutetium-177 DOTA-Tyr3-octreotate. Pasireotide achieved improved biochemical control, while peptide receptor radionuclide therapy contributed to long-term structural stability. After 23 years of follow-up, the patient remains clinically well with stable tumor burden and controlled somatotropic axis. This case highlights the natural history of a pediatric-onset GHRH-secreting neuroendocrine tumor and highlights the efficacy of aggressive, multidisciplinary management in achieving long-term survival.

Schlagwörter

Stichwörter der Autor:innen

bronchial neuroendocrine tumorectopic growth hormone–releasing hormone secretiongigantismpeptide receptor radionuclide therapypituitary hyperplasiasomatostatin analogs

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Hospital Universitario Príncipe de Asturias, Madrid 28806, Spain.
  • Department of Endocrinology and Nutrition, University and Polytechnic Hospital La Fe, Valencia 46026, Spain.
  • Medicine Department, University of Valencia, Valencia 46010, Spain.

ORCID-Profile: Fernando Vidal-Ostos De Lara, David Sanchis-Pascual, Lorena Hernández-Rienda, María Isabel Del Olmo-García

Förderung

  • Recordati Rare Diseases

Zitieren

APA

Vidal-Ostos De Lara, F., Sanchis-Pascual, D., Hernández-Rienda, L., & Del Olmo-García, M. I. (2026). Pediatric gigantism due to ectopic growth hormone releasing hormone secretion from a metastatic bronchial neuroendocrine tumor. JCEM Case Reports, 4(12). https://doi.org/10.1210/jcemcr/luag304

Vancouver

Vidal-Ostos De Lara F, Sanchis-Pascual D, Hernández-Rienda L, Del Olmo-García MI. Pediatric gigantism due to ectopic growth hormone releasing hormone secretion from a metastatic bronchial neuroendocrine tumor. JCEM Case Reports. 2026;4(12). doi:10.1210/jcemcr/luag304

BibTeX
@article{VidalOstosDeLara2026,
  author = {Vidal-Ostos De Lara, Fernando and Sanchis-Pascual, David and Hernández-Rienda, Lorena and Del Olmo-García, María Isabel},
  title = {Pediatric gigantism due to ectopic growth hormone releasing hormone secretion from a metastatic bronchial neuroendocrine tumor},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {12},
  doi = {10.1210/jcemcr/luag304}
}
Kostenlos starten →